U.S. Medical Equipment Stock News

In May 2026, 3M announced that it and a group of technology and infrastructure leaders, including Amphenol, formed a new multi-source agreement to develop open, interoperable expanded beam optical connector specifications for AI data centers, aiming to simplify deployment and improve reliability in high-density environments. This alliance underscores Amphenol’s role in shaping emerging fiber optic standards for AI infrastructure, aligning its connector portfolio with the technical...

PVH (PVH) is back in focus after a broad refresh of its leadership team, including Adelyn Cheong’s promotion to CEO of PVH Americas and new appointments across licensing and consumer strategy. See our latest analysis for PVH. The leadership reshuffle lands as PVH’s share price trades at $88.92, with a 1-day share price return of 2.55% and 7-day share price return of 10.69%. This contrasts with a 30-day share price return that is down 5.04%, while the 90-day share price return of 28.78% and...

IBM (NYSE:IBM) is receiving a US$1b investment from the U.S. Department of Commerce to create Anderon, a new quantum chip foundry subsidiary. IBM will match the government funding and contribute intellectual property and talent to build the nation's first pure-play quantum chip foundry. Anderon is intended to serve multiple quantum vendors and clients, positioning IBM at the center of the emerging U.S. quantum hardware ecosystem. For investors watching NYSE:IBM, this move extends the...

Penguin Solutions (PENG) is back on radar after appointing Nokia executive David Heard to its board, a move directly tied to the company’s push into AI infrastructure and advanced memory technologies. See our latest analysis for Penguin Solutions. The board appointment and sector-wide enthusiasm around AI infrastructure have arrived during a strong run, with a 30-day share price return of 73.38% and a 1-year total shareholder return of 201.64%. This suggests momentum has been building rather...

Why United States Antimony’s Latest Earnings Are Drawing Attention United States Antimony (UAMY) reported first quarter 2026 results that showed sales of US$6.78 million compared with US$7 million a year earlier, alongside a shift from net income to a net loss of US$11.29 million. See our latest analysis for United States Antimony. The earnings setback comes after a sharp run in the stock, with a year to date share price return of 41.99% and a 1 year total shareholder return above 200%...

CEVA, Inc. recently reported first-quarter 2026 results showing revenue of US$27.02 million versus US$24.25 million a year earlier, alongside a net loss of US$4.46 million and a new major customer win for its integrated Bluetooth High Data Throughput solution incorporating internally developed RF technology. This combination of higher revenue and a move toward more integrated wireless platforms suggests CEVA is deepening its role within customers’ connectivity roadmaps across multiple...

Gap (GAP) is back on investor radars after the stock jumped 6.6% following the appointment of Donald Kohler as President and CEO of Banana Republic, effective July 2026. See our latest analysis for Gap. That 6.6% jump sits against a mixed backdrop, with the share price up 12.8% over the past week but down 6.4% over 30 days and 7.2% year to date. The 3 year total shareholder return of roughly 3x signals longer term momentum that has previously been strong. If this kind of leadership driven...

Event overview and why it matters for Sharplink stock Sharplink (NasdaqCM:SBET) just entered a non binding memorandum of understanding with Galaxy Digital to create the Galaxy Sharplink Onchain Yield Fund, LP, a private vehicle focused on onchain yield strategies. The planned fund would start with US$125 million, including US$100 million from Sharplink's staked Ethereum treasury and US$25 million from Galaxy. It is intended to put Sharplink's existing digital assets to more active use. See...

In May 2026, Amkor Technology, Inc. expanded its Arizona advanced semiconductor packaging and test campus by securing an additional 67-acre parcel and reaffirmed its capital-return framework with a quarterly cash dividend of US$0.08352 per share. At its 2026 Investor Day, the company detailed an Arizona build-out central to its long-term growth plan while issuing 2028 financial targets that lagged market expectations and coincided with recent insider share sales. Next, we will examine how...

Earlier in May, Savara Inc. reported new Phase 3 IMPALA-2 data at the ATS 2026 meeting showing that nebulized molgramostim improved exercise capacity and related measures in adults with autoimmune pulmonary alveolar proteinosis, while also posting a wider quarterly net loss of US$37.28 million. The convergence of clinically meaningful functional gains in a rare lung disease and preparations ahead of an FDA Priority Review has sharpened attention on molgramostim’s potential role in the aPAP...

In recent months, NetScout Systems reported earnings that exceeded analyst expectations, reinforcing confidence in its operations and prompting analysts to revise earnings estimates higher. This pattern of positive surprises and upward estimate revisions has strengthened the perception that NetScout’s current execution may be better aligned with analyst expectations than previously assumed. With these earnings beats and higher forecasts in mind, we’ll now examine how this shift in...

Viasat (VSAT) is back in focus after securing a US$437.7 million government contract with Intelsat General Communications for the Protected Tactical Satellite Global program, a move that highlights its defense communications capabilities. See our latest analysis for Viasat. The contract win comes on top of a strong run in the stock, with a 30-day share price return of 20.28% and a 90-day gain of 55.59%, while the 1-year total shareholder return of around 7x suggests momentum has been building...

Recent analyst commentary on Inspire Medical Systems (INSP) has turned more cautious, highlighting reimbursement coding challenges and the need for clearer catalysts. This shift has brought renewed attention to the stock’s risk profile. See our latest analysis for Inspire Medical Systems. The recent caution from analysts comes after a period where the stock’s 30 day share price return is down 22.15% and the year to date share price return is down 52.49%, while the 1 year total shareholder...

If you are wondering whether Nasdaq at around US$91 a share is still a solid entry or more fully priced, this article walks you through what the current valuation suggests. The stock is down 1.7% over the past week and down 5.8% year to date, but it is up 12.6% over the past year and 75.1% over three years, which can signal shifting views on both its growth potential and risk. Recent coverage has focused on Nasdaq's role as a major market operator and its position in capital markets...

Revolution Medicines (RVMD) is back in focus after reporting positive Phase 3 RASolute 302 results for daraxonrasib in metastatic pancreatic ductal adenocarcinoma, highlighted in a Plenary Session at the 2026 ASCO Annual Meeting. See our latest analysis for Revolution Medicines. The stock has been volatile but firmly upward over the past year, with a 30 day share price return of 12.02%, a 90 day move of 44.58% and a very large 1 year total shareholder return, as data readouts and new coverage...

Recent performance snapshot for RBC Bearings stock Without a fresh company specific headline driving the move, RBC Bearings (RBC) has attracted attention after a year of strong longer term returns alongside a recent pullback over the past month. The stock is up about 55% over the past year and roughly 172% over the past 3 months, yet it has fallen about 5% over the past month and about 2% over the past 3 months, highlighting a mix of momentum and recent consolidation. See our latest analysis...

MasTec recently reported its strongest-ever first quarter, with revenues up 34%, adjusted EPS rising very sharply year over year, and a record US$20.30 billion backlog that led management to raise full‑year 2026 guidance for revenue, adjusted EBITDA, and EPS. Beyond the headline growth, the company’s 1.4x book‑to‑bill ratio and 28% year‑over‑year increase in its 18‑month backlog underline broad-based, longer‑term demand across Clean Energy, Infrastructure, and Pipeline projects. We’ll now...

Event overview and recent stock context Travelers Companies (TRV) recently drew investor attention as its stock performance over the past month and past 3 months contrasted with mixed annual revenue and net income trends, prompting a closer look at the insurer's current position. See our latest analysis for Travelers Companies. At a share price of $306.46, Travelers Companies has seen steady share price momentum this year, with a 7.46% year to date share price return and a 5 year total...

Brunswick (BC) stock gained 5.2% after easing bond market pressures and lower oil prices improved sentiment toward consumer-focused companies, drawing attention to how macro shifts intersect with this US$5.3b leisure and marine business. See our latest analysis for Brunswick. That 5.2% intraday move sits within a mixed picture, with a 7 day share price return of 5.87% and a 90 day share price return that is down 3.35%. The 1 year total shareholder return of 66.61% contrasts with a 5 year...

Recent performance snapshot Columbia Financial (CLBK) has drawn fresh attention after a period of solid share price gains. The stock closed at $20.36 and posted positive returns over the past month and past 3 months. For context, the stock shows a 12.1% return over the past month and 13.2% over the past 3 months. Year to date it is up 32.0%, and it has gained 43.4% over the past year, based on the figures provided. See our latest analysis for Columbia Financial. That recent upswing in the...

Earlier in May 2026, Innospec Inc. announced a 5.7% increase in its semi-annual dividend, authorized a new US$75.00 million share repurchase program, and reported first-quarter revenue up 3% year over year alongside lower adjusted EBITDA and EPS. An interesting angle is how Innospec is simultaneously returning more cash to shareholders and absorbing weaker profitability metrics, signaling management confidence despite mixed quarterly results. We’ll now examine how the higher dividend and new...

Tidewater recently saw its shares come under pressure after crude oil prices fell on reports of a potential U.S.–Iran peace draft, which eased geopolitical risk premiums and weighed on the broader offshore energy sector. Investor sentiment toward Tidewater was further affected by disappointing revenue news from a major offshore driller and recent insider share sales, even though these factors have not signaled a clear change in the company’s underlying business outlook. We’ll now examine how...

Earlier this month, Regions Financial Corporation’s shareholders approved Charter and By-Law amendments that removed certain supermajority voting rules, eased business combination restrictions, and expanded liability protections for specific officers, with these changes becoming effective between May 6 and May 11, 2026. These governance adjustments meaningfully shift how power is distributed between shareholders, management, and the board, potentially influencing future corporate decisions...

What LTC Properties stock performance tells you right now LTC Properties (LTC) has delivered mixed share performance, with the stock up about 0.6% over the past month but down roughly 1.5% over the past 3 months, prompting closer attention from income focused REIT investors. See our latest analysis for LTC Properties. At a share price of $38.48, LTC’s recent 1 day share price dip of 0.4% contrasts with an 11.1% year to date share price return and a 16.1% total shareholder return over one...